Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics (TM), today announced that Alan A. Musso, Senior Vice President, Finance and Administration and Chief Financial Officer, is scheduled to present at the Jefferies 2011 Global Healthcare Conference at Grand Hyatt New York in New York City on Thursday, June 9, 2011 at 3:30 p.m. Eastern Time.
